Literature DB >> 23824825

Ebolavirus VP35 coats the backbone of double-stranded RNA for interferon antagonism.

Shridhar Bale1, Jean-Philippe Julien, Zachary A Bornholdt, Alexander S Krois, Ian A Wilson, Erica Ollmann Saphire.   

Abstract

Recognition of viral double-stranded RNA (dsRNA) activates interferon production and immune signaling in host cells. Crystal structures of ebolavirus VP35 show that it caps dsRNA ends to prevent sensing by pattern recognition receptors such as RIG-I. In contrast, structures of marburgvirus VP35 show that it primarily coats the dsRNA backbone. Here, we demonstrate that ebolavirus VP35 also coats the dsRNA backbone in solution, although binding to the dsRNA ends probably constitutes the initial binding event.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23824825      PMCID: PMC3753998          DOI: 10.1128/JVI.01452-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

Review 1.  Experimental approaches to evaluate the thermodynamics of protein-drug interactions.

Authors:  Walter Filgueira de Azevedo; Raquel Dias
Journal:  Curr Drug Targets       Date:  2008-12       Impact factor: 3.465

2.  Ebolavirus VP35 uses a bimodal strategy to bind dsRNA for innate immune suppression.

Authors:  Christopher R Kimberlin; Zachary A Bornholdt; Sheng Li; Virgil L Woods; Ian J MacRae; Erica Ollmann Saphire
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-14       Impact factor: 11.205

Review 3.  Structural basis of innate immune recognition of viral RNA.

Authors:  Ian C Berke; Yue Li; Yorgo Modis
Journal:  Cell Microbiol       Date:  2012-11-21       Impact factor: 3.715

4.  Structural basis for Marburg virus VP35-mediated immune evasion mechanisms.

Authors:  Parameshwaran Ramanan; Megan R Edwards; Reed S Shabman; Daisy W Leung; Ariel C Endlich-Frazier; Dominika M Borek; Zbyszek Otwinowski; Gai Liu; Juyoung Huh; Christopher F Basler; Gaya K Amarasinghe
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-26       Impact factor: 11.205

5.  Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients.

Authors:  S Baize; E M Leroy; M C Georges-Courbot; M Capron; J Lansoud-Soukate; P Debré; S P Fisher-Hoch; J B McCormick; A J Georges
Journal:  Nat Med       Date:  1999-04       Impact factor: 53.440

6.  Human asymptomatic Ebola infection and strong inflammatory response.

Authors:  E M Leroy; S Baize; V E Volchkov; S P Fisher-Hoch; M C Georges-Courbot; J Lansoud-Soukate; M Capron; P Debré; J B McCormick; A J Georges
Journal:  Lancet       Date:  2000-06-24       Impact factor: 79.321

7.  Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35.

Authors:  Daisy W Leung; Kathleen C Prins; Dominika M Borek; Mina Farahbakhsh; JoAnn M Tufariello; Parameshwaran Ramanan; Jay C Nix; Luke A Helgeson; Zbyszek Otwinowski; Richard B Honzatko; Christopher F Basler; Gaya K Amarasinghe
Journal:  Nat Struct Mol Biol       Date:  2010-01-17       Impact factor: 15.369

8.  Protection from lethal infection is determined by innate immune responses in a mouse model of Ebola virus infection.

Authors:  Siddhartha Mahanty; Manisha Gupta; Jason Paragas; Mike Bray; Rafi Ahmed; Pierre E Rollin
Journal:  Virology       Date:  2003-08-01       Impact factor: 3.616

9.  Structure of the Ebola VP35 interferon inhibitory domain.

Authors:  Daisy W Leung; Nathaniel D Ginder; D Bruce Fulton; Jay Nix; Christopher F Basler; Richard B Honzatko; Gaya K Amarasinghe
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-02       Impact factor: 11.205

10.  Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae.

Authors:  Jens H Kuhn; Yiming Bao; Sina Bavari; Stephan Becker; Steven Bradfute; J Rodney Brister; Alexander A Bukreyev; Kartik Chandran; Robert A Davey; Olga Dolnik; John M Dye; Sven Enterlein; Lisa E Hensley; Anna N Honko; Peter B Jahrling; Karl M Johnson; Gary Kobinger; Eric M Leroy; Mark S Lever; Elke Mühlberger; Sergey V Netesov; Gene G Olinger; Gustavo Palacios; Jean L Patterson; Janusz T Paweska; Louise Pitt; Sheli R Radoshitzky; Erica Ollmann Saphire; Sophie J Smither; Robert Swanepoel; Jonathan S Towner; Guido van der Groen; Viktor E Volchkov; Victoria Wahl-Jensen; Travis K Warren; Manfred Weidmann; Stuart T Nichol
Journal:  Arch Virol       Date:  2012-09-23       Impact factor: 2.574

View more
  24 in total

1.  Differential Regulation of Interferon Responses by Ebola and Marburg Virus VP35 Proteins.

Authors:  Megan R Edwards; Gai Liu; Chad E Mire; Suhas Sureshchandra; Priya Luthra; Benjamin Yen; Reed S Shabman; Daisy W Leung; Ilhem Messaoudi; Thomas W Geisbert; Gaya K Amarasinghe; Christopher F Basler
Journal:  Cell Rep       Date:  2016-02-11       Impact factor: 9.423

2.  Predictive and comparative analysis of Ebolavirus proteins.

Authors:  Qian Cong; Jimin Pei; Nick V Grishin
Journal:  Cell Cycle       Date:  2015-07-09       Impact factor: 4.534

Review 3.  Innate immune evasion by filoviruses.

Authors:  Christopher F Basler
Journal:  Virology       Date:  2015-04-03       Impact factor: 3.616

Review 4.  Viral proteins that bind double-stranded RNA: countermeasures against host antiviral responses.

Authors:  Robert M Krug
Journal:  J Interferon Cytokine Res       Date:  2014-06       Impact factor: 2.607

5.  A VP35 Mutant Ebola Virus Lacks Virulence but Can Elicit Protective Immunity to Wild-Type Virus Challenge.

Authors:  Courtney Woolsey; Andrea R Menicucci; Robert W Cross; Priya Luthra; Krystle N Agans; Viktoriya Borisevich; Joan B Geisbert; Chad E Mire; Karla A Fenton; Allen Jankeel; Sneha Anand; Hideki Ebihara; Thomas W Geisbert; Ilhem Messaoudi; Christopher F Basler
Journal:  Cell Rep       Date:  2019-09-17       Impact factor: 9.423

Review 6.  Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus.

Authors:  Ilhem Messaoudi; Gaya K Amarasinghe; Christopher F Basler
Journal:  Nat Rev Microbiol       Date:  2015-10-06       Impact factor: 60.633

7.  Crystal Structure of the Marburg Virus VP35 Oligomerization Domain.

Authors:  Jessica F Bruhn; Robert N Kirchdoerfer; Sarah M Urata; Sheng Li; Ian J Tickle; Gérard Bricogne; Erica Ollmann Saphire
Journal:  J Virol       Date:  2017-01-03       Impact factor: 5.103

8.  Effects of Filovirus Interferon Antagonists on Responses of Human Monocyte-Derived Dendritic Cells to RNA Virus Infection.

Authors:  Benjamin C Yen; Christopher F Basler
Journal:  J Virol       Date:  2016-04-29       Impact factor: 5.103

9.  Impact of Měnglà Virus Proteins on Human and Bat Innate Immune Pathways.

Authors:  Caroline G Williams; Joyce Sweeney Gibbons; Timothy R Keiffer; Priya Luthra; Megan R Edwards; Christopher F Basler
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

Review 10.  Rodent-Adapted Filoviruses and the Molecular Basis of Pathogenesis.

Authors:  Logan Banadyga; Michael A Dolan; Hideki Ebihara
Journal:  J Mol Biol       Date:  2016-05-14       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.